NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Current Assets (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Current Assets came in at $778000.0 in Q4 2025, down 82.33% year-over-year from $4.4 million in Q4 2024, and down 50.0% quarter-over-quarter from $1.6 million in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Current Assets (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Current Assets across 6 years of filings, most recently posting $778000.0 for Q4 2025.

  • In Q4 2025, Current Assets fell 82.33% year-over-year to $778000.0; the TTM figure through Dec 2025 stood at $778000.0 (down 82.33% YoY), while the FY2025 annual figure was $778000.0, down 82.33% from the prior year.
  • Current Assets came in at $778000.0 for Q4 2025 at NeuroSense Therapeutics, down from $1.6 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $14.0 million in Q1 2022 to a low of $778000.0 in Q4 2025.
  • Average Current Assets over 5 years is $5.6 million, with a median of $5.0 million recorded in 2023.
  • Year-over-year, Current Assets surged 1389.82% in 2021 and plunged 84.62% in 2024.
  • Over 5 years, Current Assets stood at $11.4 million in 2021, then sank by 35.32% to $7.4 million in 2022, then sank by 60.49% to $2.9 million in 2023, then jumped by 50.96% to $4.4 million in 2024, then plunged by 82.33% to $778000.0 in 2025.
  • Per Business Quant data, the three most recent Current Assets figures were $778000.0 in Q4 2025, $1.6 million in Q2 2025, and $4.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 18.45 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 5.82 Bn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 8.07 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 4.74 Bn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 778,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 778,000.00
Jun 30, 2025 1.56 Mn
Dec 31, 2024 4.40 Mn
Sep 30, 2024 785,000.00
Jun 30, 2024 1.62 Mn
Mar 31, 2024 1.19 Mn
Dec 31, 2023 2.92 Mn
Sep 30, 2023 5.11 Mn
Jun 30, 2023 7.56 Mn
Mar 31, 2023 5.02 Mn
Dec 31, 2022 7.38 Mn
Sep 30, 2022 8.89 Mn
Jun 30, 2022 11.10 Mn
Mar 31, 2022 14.03 Mn
Dec 31, 2021 11.41 Mn
Dec 31, 2020 766,000.00
API Access

NeuroSense Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY